Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Oral Care for Prevention of Non-ventilator Hospital-acquired Pneumonia
NCT04403971Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- May 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of chlorhexidine in hospital-acquired pneumonia (HAP) (3 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Oral bacterial colonization status at 1 year. Started May 2020; status: completed.
02
Drugs
chlorhexidine
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT04403971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403971.